| 2D Structure | |
| CID | 442427 |
| Target | / |
| IUPAC Name | (4S,4aS,7S,7aR)-4,7-dimethyl-4,4a,5,6,7,7a-hexahydro-1H-cyclopenta[c]pyran-3-one |
| InChI | InChI=1S/C10H16O2/c1-6-3-4-8-7(2)10(11)12-5-9(6)8/h6-9H,3-5H2,1-2H3/t6-,7-,8+,9+/m0/s1 |
| InChI Key | LYEFRAMOOLOUKA-RBXMUDONSA-N |
| Canonical SMILES | CC1CCC2C1COC(=O)C2C |
| Isomeric SMILES | C[C@H]1CC[C@H]2[C@@H]1COC(=O)[C@H]2C |
| Molecular Formula | C10H16O2 |
| Molecular Weight | 168.23 |
| synonyms | ['Iridomyrmecin', 'Iridomyrmexin', '485-43-8', 'Iridomirmecina', '(+)-Iridomyrmecin', 'UNII-9736R92EPU', '9736R92EPU', '(4S,4aS,7S,7aR)-4,7-dimethyl-4,4a,5,6,7,7a-hexahydro-1H-cyclopenta[c]pyran-3-one', 'NSC 10974', 'IRIDOMYRMECIN [MI]', 'IRIDOMYRMECIN, (+)-', 'DTXSID40876125', 'NSC-10974', '.ALPHA.-(2-HYDROXYMETHYL-3-METHYLCYCLOPENTANE)PROPIONIC ACID .DELTA.-LACTONE', 'CYCLOPENTA(C)PYRAN-3(1H)-ONE, HEXAHYDRO-4,7-DIMETHYL-, (4S,4AS,7S,7AR)-', 'Cyclopenta(c)pyran-3(1H)-one, hexahydro-4,7-dimethyl-, (4S-(4alpha,4abeta,7beta,7abeta))-', 'CYCLOPENTA(C)PYRAN-3(1H)-ONE, HEXAHYDRO-4,7-DIMETHYL-, (4S-(4.ALPHA.,4A.BETA.,7.BETA.,7A.BETA.))-', 'Cyclopenta(c)pyran-3(1H)-one, hexahydro-4,7-dimethyl-', 'Cyclopenta[c]pyran-3(1H)-one, hexahydro-4,7-dimethyl-', '(4S,4aS,7S,7aR)-4,7-dimethyl-4,4a,5,6,7,7a-hexahydro-1H-cyclopenta(c)pyran-3-one', 'Cyclopenta[c]pyran-3(1H)-one, hexahydro-4,7-dimethyl-, (4.alpha.,4a.beta.,7.beta.,7a.beta.)-(-)-', 'Cyclopenta[c]pyran-3(1H)-one, hexahydro-4,7-dimethyl-, [4S-(4.alpha.,4a.beta.,7.beta.,7a.beta.)]-', 'DTXCID701014237', 'ALPHA-(2-HYDROXYMETHYL-3-METHYLCYCLOPENTANE)PROPIONIC ACID DELTA-LACTONE', 'Cyclopenta(c)pyran-3(1H)-one, hexahydro-4,7-dimethyl-, (4alpha,4abeta,7beta,7abeta)-(-)-', 'lyeframoolouka-hxflibjxsa-n', 'lyeframoolouka-uhfffaoysa-n', 'C09786', 'AC1L9CSW', 'SureCN1649438', 'CHEBI:5967', 'SCHEMBL1649438', 'NS00010504', 'Q2016116', '(4S,4AS,7S,7aR)-4,7-dimethylhexahydrocyclopenta[c]pyran-3(1H)-one'] |
From Pubchem